| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8771199 | The Journal of Urology | 2018 | 7 Pages | 
Abstract
												Focal therapy hemiablation is safe with little alteration of functional outcome. The oncologic outcome is acceptable on short-term followup. Followup multiparametric magnetic resonance imaging performed poorly and should not replace repeat biopsy. Focal therapy has no impact on posttreatment anxiety and depression.
											Keywords
												PI-RADS™PSAmpMRITRUSHIFUI-PSSTUR-PIIEFCSPCHADS-DQuality of lifeMultiparametric MRIProstate specific antigenMRITransurethral resection of prostateMagnetic resonance imagingFocal therapyProstate cancerTransrectal ultrasoundhigh intensity focused ultrasoundhigh-intensity focused ultrasound ablationInternational Index of Erectile FunctionProstatic neoplasmsSurveys and questionnairesInternational Prostate Symptom ScoreProstate Imaging Reporting and Data System
												Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Nephrology
												
											Authors
												Roman Ganzer, Boris Hadaschik, Sascha Pahernik, Daniel Koch, Daniel Baumunk, Timur Kuru, Axel Heidenreich, Jens-Uwe Stolzenburg, Martin Schostak, Andreas Blana, 
											